News
Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...
Company currently initiating additional trial sites and working with study investigators to enroll participants IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit ...
4hon MSN
Some 50,000 Australians will die from cancer this year, despite big breakthroughs in treatments. What makes cancer so very ...
Negative Breast Cancer Market Insight, Epidemiology and Market Forecast - 2035" report delivers comprehensive insights into triple-negative breast cancer, i ...
These pathological consequences are amplified in the context of mutations in repair-related genes like BRCA1 and BRCA2, underlining their relevance in diseases such as cancer and neurodegeneration.
Harmful mutations in BRCA2 were also linked to significantly ... where the HER2 oncogene was overexpressed. Given its novel mechanism of action and proven efficacy, Herceptin was granted ...
Germline mutations in the BRCA1 gene increase the lifetime risk of breast cancer to as high as 80%. Preventive measures and early detection strategies remain limited, largely due to an incomplete ...
Genetic tests are needed to establish whether your cancer has the specific genetic mutations, including BRCA mutations ... Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results